PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,299,745
|
intend unintend impact comprehens reform urban public hospit mix method studi hangzhou china public hospit reform key area chines healthcar system reform aim control excess growth medic expenditur studi aim evalu impact two round urban public hospit reform respect start
|
D018166;D006779
|
T064;T073;T093
|
36,299,744
|
screen time myopia serial multipl mediat sem analysi covid influenc educ system worldwid signific increas screen time colleg student pose potenti risk myopia china nineti percent colleg student suffer myopia excess screen time chang colleg student lifestyl impos potenti health risk affect opportun employ import identifi potenti correl screen time use myopia among colleg student
|
D000086382;D009216
|
T047;T067
|
36,299,743
|
associ aldehyd exposur kidney stone adult environment pollut sourc may play key role pathogenesi nephrolithiasi although link environment aldehyd exposur incid nephrolithiasi unclear research studi set see whether adult kidney stone format link environment aldehyd examin data adult particip age took part nation health nutrit examin survey nhane cross section research logist regress model employ work examin relationship aldehyd exposur kidney stone machin learn util predict connect differ paramet develop kidney stone subgroup analysi perform identifi sensit group control confound variabl result reveal isopentanaldehyd benzaldehyd hexanaldehyd risk factor kidney stone format odd ratio respect percent confid interv ci kidney stone may result long term exposur aldehyd may caus form environment pollut relat aldehyd exposur might give novel notion direct futur studi process kidney stone product even caus yet unknown
|
D001547;D007669
|
T047;T109
|
36,299,742
|
person assist england factor associ absente person assist pas becom increas import element long term care ltc england sinc introduct direct payment care act legisl pas direct employ social care user perform number support task includ vital assist activ daili live adl intern role would class domest care work includ employ migrant care worker eg germani austria high turnov rate work absente market caus disrupt import daili activ caus ltc user potenti suffer neglect poorer qualiti life although research turnov absente nurs workforc hospit ltc worker nurs home littl attent given reason turnov pas even less absente often preced turnov workforc peopl england research aim fill gap knowledg analyz reason behind absente pas use quantit method use survey data pas england explor factor associ one form absente sick leav work control number factor rang job characterist number hour work type contract socio econom characterist pa employ suppli demand factor local govern region find suggest number factor signific influenc sick leav includ distanc travel work number pas employ follow analysi two peopl life experi ltc discuss find studi compar experi market pas provid uniqu perspect peopl could benefit improv pa retent reduc absente
|
D000041;D000203
|
T055;T056;T080
|
36,299,741
|
parent smoke exposur pregnanc offspr attent deficithyperact disord risk chines child adolesc cohort studi previous studi reveal matern smoke exposur pregnanc essenti risk factor offspr develop attent deficithyperact disord adhd impact patern smoke exposur year pregnanc offspr adhd risk still unclear
|
D001289;D014028;D011297
|
T033;T069;T037;T048
|
36,299,740
|
health relat qualiti life treatment satisfact patient cardiovascular diseas ethiopia cardiovascular diseas preval health problem associ poorer health relat qualiti life hrqol aim assess hrqol treatment satisfact cardiovascular diseas patient ethiopia
|
D011788;D002318
|
T078;T047
|
36,299,739
|
promot activ age older adult educ context popul age enter era popul age mani public health problem associ age becom serious older adult earlier onset chronic diseas suffer disabl therefor extrem import promot activ age enhanc health literaci involv full consider need educ provis solut problem associ age develop oae import measur implement strategi activ age curriculum construct fundament compon achiev oae various subject object factor limit develop oae overcom difficulti ensur activ healthi age requir activ age implement limit current oae address system integr increas curriculum system improv approach help achiev goal activ age paper discuss oae perspect activ age base promot health literaci provid suggest protect physic mental health among older adult promot social particip provis various social guarante normal life older adult new educ concept
|
D000073656
|
T102
|
36,299,738
|
attitud influenc factor patient schizophrenia toward long act inject communiti base cross section investig china low prescript rate antipsychot long act inject lai may major challeng prevent treatment schizophrenia howev studi usag attitud toward lai among communiti base patient schizophrenia
|
D012559;D014150
|
T121;T039;T048
|
36,299,706
|
network pharmacolog base dissect mechan drynaria rhizoma low back pain explain potenti mechan drynaria rhizoma dr treatment low back pain lbp
|
D029621;D017116;D004365
|
T184;T121;T123;T047;T002
|
36,299,705
|
bacteri profil antimicrobi suscept pattern associ factor among dental cari suspect patient attend ayder comprehens special hospit privat dental clinic mekell northern ethiopia dental cari major public oral infecti diseas global due high preval signific social impact mani studi conduct dental cari ethiopia howev fail convey antimicrobi resist oral environ
|
D002440;D003731
|
T033;T047;T195;T109
|
36,299,704
|
serum marker ca ca cea along inflammatori cytokin earli detect lung cancer high risk popul lung cancer mortal morbid rate first among malign tumor extrem crucial pay attent earli diagnosi treatment lung cancer grasp judg progress patient condit prompt studi lung cancer patient earli diagnosi tumor marker inflammatori variabl examin general surgeri depart hospit treat patient lung cancer patient benign pulmonari hyperplasia januari februari addit healthi subject complet physic examin time period includ base find patholog examin patient benign pulmonari hyperplasia chosen benign group patient lung cancer chosen malign group healthi individu chosen healthi group tumor marker carbohydr antigen ca ca carcinoembryon antigen cea well inflammatori factor tumor necrosi factor tnf high sensit c reactiv protein measur venous blood three group patient hs crp discern differ tumor marker level benign healthi group p comparison benign healthi group malign group higher serum level ca ca cea p benign healthi group discern differ level inflammatori factor p tnf hs crp serum level observ higher malign group compar benign healthi group p combin detect ca ca cea tnf hs crp show highest sensit specif respect percent percent compar singl mix detect tumor marker inflammatori factor sole serum level inflammatori agent tnf hs crp may relat pathophysiolog function patient lung cancer well develop metastasi diseas marker includ ca ca cea earli detect lung cancer evalu diseas sever detect tumor marker combin inflammatori variabl signific refer valu
|
D002272;D008175
|
T129;T191;T116
|
36,299,685
|
bioinformat analysi identifi tnfrsfa biomark liver injuri sepsi tnfrsfa biomark septic liver injuri sepsi sever diseas high mortal liver injuri independ risk factor sepsi morbid mortal analyz co differenti express gene co deg explor potenti biomark therapeut target sepsi relat liver injuri three gene express dataset gse gse gse download gene express omnibus geo deg screen sepsi control sampl use geor associ deg infect liver diseas analyz use ctd databas go function analysi kegg pathway enrich analysi protein protein interact ppi network analysi perform elucid potenti molecular mechan deg deg differ tissu gse analyz obtain specif marker septic liver injuri mous model sepsi also establish cecal ligat punctur clp express specif marker liver lung kidney tissu analyz use western blot identifi deg three dataset hub gene show higher infer score liver diseas bacteri infect among tnfrsfa liver specif differenti express tnfrsfa also confirm specif reduc septic liver tissu mice therefor tnfrsfa may serv potenti biomark septic liver injuri
|
D019295;D018805
|
T047;T046;T091
|
36,299,684
|
associ extracellular matrix protein gene polymorph progress liver diseas studi aim investig relationship extracellular matrix ecm gene polymorph progress liver fibrosi chines popul
|
D008113;D006528;D019694;D004066
|
T047;T191
|
36,299,683
|
molecular character wild cultiv strawberri fragaria ananassa dna barcod marker dna barcod use techniqu identif conserv divers estim speci level plant current research work carri character select fragaria speci northern pakistan use dna barcod marker methodolog initi efficaci eight dna barcod marker analyz base amplif sequenc genom select fragaria speci result sequenc analyz use blast mega bio edit softwar phylogenet tree construct use fragaria current speci sequenc refer sequenc neighbor join method maximum likelihood method
|
D031985
|
T168;T002
|
36,299,682
|
effect core stabil train unstabl support surfac postop rehabilit thoracolumbar vertebr compress fractur elder thoracolumbar vertebr compress fractur tvcf caus anterior flexion vertic downward violenc spine sezer et al studi aim investig effect core stabil train cst unstabl support surfac postop rehabilit tvcf elder method nineti eight patient tvcf underw surgic treatment hospit juli april select studi subject divid research group receiv unstabl support surfac cst control group convent rehabilit train accord random number tabl method train x ray machin posit anterior margin middl height ratio posterior convex cobb angl injur vertebra observ balanc detector use detect patient eye open close trajectori length romberg rate perform gait test patient pain lumbar spine function qualiti life subsequ assess use visual analogu scale vas oswestri dysfunct index odi generic qualiti life inventori gqol patient satisfact rehabilit investig result rehabilit train statist mark differ eye open trajectori length group p research group higher score control group dimens anterior border injur vertebra middl height ratio gqol posterior convex cobb angl close eye trajectori length romberg rate vas odi lower control group p research group also reveal better gait improv higher rehabilit satisfact control group train p
|
D050815;D016103
|
T046;T037
|
36,299,681
|
dynam monitor serum protein acut respiratori distress syndrom base artifici neural network acut respiratori distress syndrom ard one serious diseas human lung diseas reduc incid rate import task current clinic research dynam monitor serum protein patient help achiev earli diagnosi treatment ard studi protein monitor model base artifici neural network propos first surfac enhanc laser desorpt ionize time flight mass spectrometri use protein detect bp neural network use protein classif content analysi experiment analysi serum sampl patient acut respiratori distress syndrom hospit novemb august select experiment test experiment result show serum protein monitor model base bp neural network low error high converg abil monitor individu protein protein monitor area roc curv diagnost perform reach result show artifici neural network good effect dynam monitor serum protein acut respiratori distress syndrom diagnost perform evalu reach abil signific improv clinic diagnosi treatment acut respiratori distress syndrom
|
D012128
|
T047
|
36,299,680
|
identif lncrnas associ pathogenesi diabet retinopathi sequenc analysi valid via vivo vitro experi studi aim screen differenti express long noncod rnas lncrnas associ pathogenesi diabet retinopathi verifi role lncznrd high glucos induc injuri retin microvascular endotheli cell retin tissu normal diabet rat collect high throughput sequenc differenti express lncrnas retin microvascular endotheli cell treat mm glucos h h h h h result show compar control group differenti express lncrnas retina tissu model group includ upregul gene downregul gene base differenti express lncrnas kyoto encyclopedia gene genom kegg analysi indic erbb signal pathway transform growth factor tgf signal pathway pik akt signal pathway cyclic adenosin monophosph camp signal pathway mitogen activ protein kinas mapk signal pathway hypoxia induc factor hif signal pathway like involv regul diabet retinopathi compar control group express lncznrd signific increas retin microvascular endotheli cell treatment high glucos h silenc lncznrd promot high glucos induc apoptosi microvascular endotheli cell addit silenc lncznrd increas express level aldha aldha conclus lncznrd demonstr potenti benefici function high glucos induc retina cell injuri regul aldha aldha express
|
D062085;D003930;D003921
|
T123;T047;T050;T114
|
36,299,679
|
function heparin sodium inject prevent peripher insert central cathet relat venous thrombosi nsclc patient postop chemotherapi studi intend analyz hazard factor venous thrombosi compar effect differ dose heparin sodium inject incid rate peripher insert central cathet picc relat venous thrombosi non small cell lung carcinoma nsclc patient postop chemotherapi
|
D002405;D002289;D054556;D020246;D008175
|
T061;T047;T191;T046
|
36,299,678
|
effect nonpharmacolog integr care protocol patient fatigu undergo hemodialysi random control trial studi design investig effect nonpharmacolog integr care protocol fatigu patient hemodialysi parallel random control trial conduct patient undergo hemodialysi may octob dialysi center fifth affili hospit zunyi medic univers patient random intervent group accept nonpharmacolog integr care protocol standard care control group accept standard care use comput generat random number nonpharmacolog holist care intervent use studi involv well round multidisciplinari team work togeth improv dietari complianc medic adher self manag improv patient care promot self manag evalu patient case elig analyz result show patient intervent group obvious reduc overal fatigu mental fatigu muscular fatigu relat control group nonpharmacolog integr care protocol interact promot meanwhil role function nurs manag chronic diseas demonstr crucial
|
D019033;D006435;D005221
|
T061;T184;T058;T093
|
36,299,625
|
gut microbiota deriv indol propion acid partial activ aryl hydrocarbon receptor promot macrophag phagocytosi attenu septic injuri sepsi associ high risk death crosstalk gut microbiota sepsi gradual reveal indol propion acid ipa gut microbiota deriv metabolit exert immun regul organ protect effect howev role ipa sepsi clear studi role ipa sepsi relat surviv clinic score bacteri burden organ injuri assess murin model cecal ligat punctur induc polymicrobi sepsi aryl hydrocarbon receptor ahr high specif inhibitor ch use observ role ahr protect ipa sepsi effect ipa bacteri phagocytosi macrophag investig vivo vitro level ipa fece measur analyz human sepsi patient patient control first found gut microbiota deriv ipa associ surviv septic mice anim model ipa administr protect sepsi relat mortal allevi sepsi induc bacteri burden organ injuri blunt ahr inhibitor next vivo vitro ipa enhanc macrophag phagocytosi ahr deplet macrophag revers protect effect ipa sepsi final day icu admiss day septic patient signific lower ipa level fece patient control also septic patient bacteremia signific lower ipa level fece compar non bacteremia furthermor septic patient reduc ipa associ wors clinic outcom ipa fece similar predict abil day mortal sofa score increas predict abil sofa score find indic gut microbiota deriv ipa protect sepsi host control infect promot macrophag phagocytosi suggest ipa may new strategi sepsi treatment
|
D000069196;D018805
|
T047;T007;T001;T046
|
36,299,624
|
periodont induc porphyromona gingivali drive impair glucos metabol mice periodont demonstr bidirect associ diabet recogn complic diabet periodont pathogen porphyromona gingivali possibl pathogen link periodont diseas system diseas also found involv occurr develop diabet studi week old male cbl mice oral administ p gingivali strain atcc week histolog analysi gingiv tissu quantifi analysi alveolar bone loss perform evalu periodont destruct bodi weight fast glucos glucos toler test gtt insulin toler test itt use evalu glucos metabol disord analyz express profil inflammatori cytokin chemokin gingiv tissu liver adipos tissu well serum result show mice p gingivali administ group develop appar gingiv inflamm alveolar bone loss compar control group week p gingivali infect signific differ observ min gtt min itt p gingivali administ mice show increas mrna express level pro inflammatori cytokin tnf il il il chemokin ccl ccl cxcl gingiva serum express level glucos metabol relat gene also chang liver adipos tissu result indic oral administr p gingivali induc chang inflammatori cytokin chemokin gingiva blood lead alveolar bone loss inflammatori chang liver adipos tissu promot glucos metabol disord mice
|
D016301;D010518;D044882;D061385
|
T121;T047
|
36,299,623
|
foxo inhibit fsl regul integrin block stat bind integrin gene promot integrin itgb epitheli specif receptor downregul gingiv epithelium periodont associ inflamm respons periodont develop howev transcript regulatori mechan itgb downregul human gingiv epithelium remain unclear fibroblast stimul lipopeptid fsl oral biofilm compon promot epitheli cell driven proinflammatori respons periodont partial suppress itgb express aim current studi investig transcript regulatori mechan itgb inhibit fsl human epitheli cell hacat primari human gingiv epitheli cell delin transcript mechan itgb suppress periodont found fsl inhibit itgb transcript increas forkhead box protein foxo express inhibit signal transduc activ transcript stat activ furthermor foxo bound stat direct lead decreas stat phosphoryl induc fsl consequ bind phosphoryl stat itgb promot decreas itgb transcript therefor downregul follow fsl stimul reciproc action stat foxo itgb downregul also confirm immunostain inflammatori epithelium associ periodont find suggest interact foxo stat may use signal target treatment periodont
|
D050796;D010518
|
T123;T047;T116
|
36,299,607
|
ros mediat enamel format disturb character altern cervic loop cell prolifer downregul rhoarock ameloblast reactiv oxygen stress ros general accept signal transduc coordin growth differenti tissu organ oral maxillofaci region although ros confirm affect develop enamel yet known specif mechan ros accumul induc enamel defect given lack knowledg role ros enamel aim studi determin oxid stress affect cervic cell ameloblast cell use sod knockout mice identifi relationship ros fluctuat abnorm enamel structur stain micro ct scan electron microscop increas ros induc h certifi dcfh probe result dual effect prolifer differenti cervic cell indic higher tendenc prolifer low ros concentr ameloblast transfect sod sirna show signific reduct rhoa rock studi investig first time sod mediat ros accumul disrupt normal enamel structur altern cervic loop cell prolifer downregul rhoa rock ameloblast demonstr convolut role ros monitor progress enamel defect
|
D000565;D010100
|
T123;T196;T121;T025
|
36,299,606
|
explor protect mechan bax remov ischemia reperfus injuri skin flap p mitogen activ protein kinas pathway research aim explor influenc bax gene p mitogen activ protein kinas mapk pathway protect mechan ischemia reperfus injuri iri skin flap forti male spragu dawley sd rat equal divid experiment group bax gene knockout rat control group dorsal flap model prepar surviv rate flap observ surgeri rat flap tissu cut stain hematoxylin eosin situ termin deoxynucleotidyl transferas mediat dutp nick end label tunel distribut characterist pmapk bax detect evalu protect mechan bax gene knockout iri skin flap surgeri surviv rate flap experiment group signific higher control group p result stain show st day surgeri compar control group skin flap rat experiment group arrang neat result tunel stain show compar control group tissu structur skin flap experiment group normal apoptot cell appear addit compar control group express bax p mapk experiment group signific decreas p short bax gene knock injuri flap ischemia reperfus consider improv may play protect role iri flap affect pmapk pathway
|
D048051;D015427;D013524;D012867
|
T116;T022;T126;T037;T023
|
36,299,605
|
dna topoisomeras ii regul mir p promot hepatocellular carcinoma invas migrat hippo pathway dna topoisomeras top dysregul various type cancer howev top ii alpha topa contribut hepatocellular carcinoma hcc progress remain elus cohort analysi reveal increas express topa associ poor clinic outcom topa signific upregul hcc tissu cell line vitro topa express level relat cell invas migrat may due alter epitheli mesenchym transit topa moreov use verteporfin hippo inhibitor test hippo pathway promot effect topa hcc phenotyp found topa induc tumor progress hippo pathway final mir p inhibit tumor progress spong topa
|
D006528;D004250;D008113;D035683
|
T123;T116;T191;T126;T114
|
36,299,604
|
corilagin restrain nlrp inflammasom activ pyroptosi rostxnipnlrp pathway prevent inflamm corilagin gallotannin show excel antioxid anti inflammatori effect nlrp inflammasom dysfunct implic varieti inflamm diseas howev remain unclear corilagin regul nlrp inflammasom reliev gouti arthriti studi bone marrow deriv macrophag bmdms pretreat lipopolysaccharid lps incub nlrp inflammasom agonist adenin nucleosid triphosph atp nigericin monosodium urat msu crystal msu crystal intra articular inject induc acut gouti arthriti show corilagin reduc lactat dehydrogenas ldh secret proport propidium iodid pi stain cell corilagin suppress express n termin pyroptosi execut protein gasdermin gsdmd nt corilagin restrict caspas p interleukin il releas meanwhil corilagin attenu asc oligomer speck format find confirm corilagin diminish nlrp inflammasom activ macrophag pyroptosi discov corilagin limit mitochondri reactiv oxygen speci ros product prevent interact txnip nlrp ros activ imiquimod could antagon inhibitori function corilagin nlrp inflammasom macrophag pyroptosi addit corilagin amelior msu crystal induc joint swell inhibit il product abat macrophag neutrophil migrat joint capsul collect result demonstr corilagin suppress rostxnipnlrp pathway repress inflammasom activ pyroptosi suggest potenti antioxid role allevi nlrp depend gouti arthriti
|
D000069292;D015210
|
T047;T043
|
36,299,603
|
prognost assess oxid stress relat gene colorect cancer new insight tumor immun oxid stress crucial biolog tumor oxid stress potenti predict signific colorect cancer crc studi nevertheless develop forecast model base oxid stress forecast result crc surviv enhanc clinic judgment train set chosen transcriptom crc patient gse valid sampl colon cancer gse util purpos choos prognost gene express oxid stress relat gene oxeg found prognost risk model built use multivari cox regress analysi univari cox regress analysi lasso regress analysi outcom western blot transcriptom sequenc test final confirm atf car crp gpx ilb mapk mrpl mtfmt nos osgin sod aar foxo among oxeg use build prognost characterist patient crc categor low risk high risk group accord median risk score cox regress analysi use singl multipl variabl reveal oxeg relat signal independ risk factor crc addit valid outcom western blot transcriptom sequenc demonstr oxeg differ express use oxeg work creat predict signatur may appli creation new prognost model identif possibl medic candid treatment crc
|
D015179
|
T191
|
36,299,602
|
novel therapeut mechan adipos deriv mesenchym stem cell osteoarthr via upregul btg osteoarthr oa debilit degen joint diseas character progress destruct articular cartilag mesenchym stem cell mscs implic treatment oa howev function adipos deriv mscs ad mscs oa under mechan remain obscur
|
D045164;D010003;D059630
|
T061;T047;T025
|
36,299,601
|
machin learn appli diagnosi method subcutan cyst ultrasonographi decad ultrasound imag wide use detect various diseas due high secur effici howev read ultrasound imag requir year experi train order support diagnosi clinician reduc workload doctor mani ultrason comput aid diagnost system propos recent year success deep learn imag classif segment made scholar realiz potenti perform improv brought applic deep learn ultrason comput aid diagnosi system studi aim appli sever machin learn algorithm develop machin learn method diagnos subcutan cyst clinic featur extract dataset imag ultrasonographi patient hunan provinci peopl hospit china dataset separ train test four kind machin learn algorithm includ decis tree dt support vector machin svm k nearest neighbor knn neural network nn approach determin best perform compar result featur svm achiev best perform result show svm perform highest accuraci diagnosi subcutan cyst ultrasonographi provid good refer applic clinic practic ultrasonographi subcutan cyst
|
D000069550;D003560
|
T190;T066
|
36,299,468
|
superior mesenter arteri occlus follow laparoscop partial fundopl year old male histori endoscop find consist gastroesophag reflux underw elect laparoscop fundopl develop sever abdomin pain four day postop comput tomographi ct angiogram abdomen demonstr occlus superior mesenter arteri due dissect patient administ intraven heparin follow vascular surgic advic result resolut pain within hour subsequ complic laparoscopi associ mesenter vascular event rare associ high morbid mortal mesenter arteri occlus frequent report follow laparoscop cholecystectomi may occur follow mani common laparoscop procedur present general occur hour day follow procedur sever abdomin pain proport physic sign left unrecogn patient progress bowel viscer ischemia necrosi multiorgan failur mechan postul caus mesenter vascular event involv chang splanchnic blood flow reduc cardiac output system venous return hypercapnia relat carbon dioxid insuffl diagnosi may made prompt ct angiographi potenti treat intraven heparin alon avoid laparotomi bowel resect first report case success anticoagul caus resolut occlus suffici avoid reoper bowel resect identifi condit treat liaison vascular surgeri colleagu may requir anticoagul endovascular open intervent
|
D008641;D010535
|
T060;T047;T061
|
36,299,464
|
involv ceramid biosynthesi increas extracellular vesicl releas pkd knock cell autosom domin polycyst kidney diseas adpkd inherit disord character develop renal cyst frequent lead renal failur hypertens cardiovascular symptom contribut high morbid mortal diseas adpkd caus mutat pkd gene less frequent pkd gene diseas onset progress high variabl patient wherebi under mechan fulli elucid recent role extracellular vesicl ev progress adpkd postul howev mechan stimul ev releas adpkd address particip distal nephron segment still uninvestig studi effect pkd defici ev releas wild type pkd mdct mimcd cell model distal convolut tubul dct inner medullari collect duct imcd respect use nanoparticl track analysi observ signific increas ev releas pkd mdct mimcd cell respect wild type cell molecular mechan lead chang ev releas investig mdct cell rna sequenc qpcr studi specif assess relev purinerg signal ceramid biosynthesi enzym pkd mdct cell show clear upregul prx express compar wild type cell deplet extracellular atp apyras ecto nucleotidas inhibit ev releas wild type cell suggest exacerb signal extracellular atppx pathway pkd cell addit identifi signific regul ceramid biosynthesi enzym cer smpd pkd cell altogeth find suggest involv dct ev mediat adpkd progress point induct ceramid biosynthesi under molecular mechan studi perform investig whether cer smpd use biomark adpkd onset progress sever
|
D002518;D000067128;D016891
|
T026;T123;T109;T019;T047
|
36,299,463
|
proteom analysi cancer tissu identifi igfr potenti therapeut target laryng carcinoma laryng cancer lc preval head neck malign howev essenti pathophysiolog mechan under tumorigenesi progress remain elus due perdur scarciti effect target drug laryng cancer insight diseas pathophysiolog mechan would substanti impact treatment landscap laryng cancer
|
D002294;D007822
|
T191
|
36,299,462
|
combin earli interleukin level predict postop nosocomi infect inflammatori respons play critic role postop nosocomi infect common postop complic caus advers event poor postop outcom studi aim explor abil earli inflamm relat factor level predict occurr nosocomi infect abdomin surgeri
|
D020382;D015850;D018945;D003428
|
T129;T047;T116
|
36,299,461
|
associ serum hydroxyvitamin bodi mass index bodi fat composit among emirati popul result uae healthi futur studi vitamin defici insuffici high preval among sever popul across globe numer studi shown signific correl bodi mass index bmi vitamin status howev result differ accord ethnic despit abund sunshin throughout year vitamin defici promin unit arab emir uae studi analyz uae healthi futur studi uaehf pilot data investig associ serum hydroxyvitamin oh bodi fat bf composit well bmi
|
D014807;D014808
|
T121;T047;T127
|
36,299,460
|
evalu role type diabet mellitus rotat cuff tendinopathi develop analysi novel rat model establish valid intact rotat cuff rat model explor pathophysiolog effect type diabet rotat cuff tendon vivo
|
D000070636;D003924;D003921;D052256
|
T033;T047;T050;T037
|
36,299,459
|
bundl format sperm influenc environment factor cooper behaviour sperm one mechan play role sperm competit observ sever speci spermatozoa interact form agglomer bundl studi investig effect physic biochem factor like promot bundl format bull sperm factor includ fluid viscos swim process post thaw incub time media addit promot capacit viscos seem influenc degre sperm bundl swim post thaw migrat time suppress capacit increas occurr sperm bundl lead conclus sperm bundl result hydrodynam adhes interact cell occur frequent prolong incub time
|
D013075;D012661
|
T031;T043
|
36,299,458
|
obes paradox age viscer adipos index caus mortal older individu prospect cohort studi relationship bodi mass index bmi mortal older adult diminish necessari examin factor may accur predict mortal older adult viscer adipos index vai uncompl marker specif gender incorpor anthropometr data lipid profil vai propos marker viscer adipos tissu dysfunct relat cardiometabol risk aim studi evalu link vai caus mortal among elder
|
D050154;D056128
|
T033;T184;T032
|
36,299,457
|
analysi serum bone turnov marker femal cynomolgus monkey differ age purpos studi examin bone turnov marker estradiol parathyroid hormon hydroxyvitamin cynomolgus monkey differ age improv understand chang bone turnov marker throughout life cycl cynomolgus monkey provid basi establish non human primat model osteoporosi
|
D011347;D000469
|
T123;T126;T116
|
36,299,456
|
effect thyroid function assist reproduct outcom euthyroid infertil women singl center retrospect data analysi systemat review meta analysi influenc thyroid stimul hormon tsh gestat outcom studi check whether differ tsh level relev human reproduct outcom intern guidelin recommend tsh valu miul women tri conceiv sinc valu level relat higher frequenc advers reproduct outcom studi aim evalu whether tsh valu correl differ gestat outcom euthyroid infertil women without autoimmun thyroid diseas
|
D007247;D013959
|
T033;T047;T046
|
36,299,455
|
machin learn base dynam predict later lymph node metastasi patient papillari thyroid cancer develop web base machin learn server predict later lymph node metastasi llnm papillari thyroid cancer ptc patient
|
D002291;D013964
|
T191
|
36,299,454
|
risk major osteoporot fractur glp receptor agonist compar dpp inhibitor danish nationwid cohort studi type diabet mellitus td associ increas fractur risk littl evid effect glucagon like peptid receptor agonist glp ra fractur risk td aim investig risk major osteoporot fractur mof treatment glp ra compar dipeptidyl peptidas inhibitor dpp add therapi metformin
|
D054873;D003924;D058866;D008687
|
T121;T047;T109
|
36,299,453
|
associ vitamin zoledron induc acut phase respons fever risk osteoporot patient elucid independ correl vitamin content zoledron zol trigger acut phase respons apr fever risk osteoporot op patient examin potenti threshold optim vitamin concentr prevent occurr zol induc fever
|
D000210;D002116
|
T125;T121;T046;T116
|
36,299,452
|
plasma lipid level risk retin vascular occlus genet studi use mendelian random causal effect plasma lipid level risk retin vascular occlus rvo clear identifi especi high densiti lipoprotein cholesterol hdl c low densiti lipoprotein cholesterol ldl c tri identifi causal risk factor use two sampl mendelian random mr analysi singl nucleotid polymorph snps chosen instrument variabl iv obtain genet variant associ lipid exposur genom wide signific p level meta analysi gwas global lipid genet consortium glgc base individu most european ancestri mr analys meanwhil use lipid gwas uk biobank ukb sampl size individu supplement obtain genet predictor rvo finngen biobank studi conduct univari multivari mr mvmr analys identifi causal effect rvo although invers varianc weight ivw primari method use mr analys mr egger weight median method use supplement ivw determin heterogen iv use cochran q test use mr egger intercept mr presso global test detect horizont pleiotropi leav one sensit analysi conduct remov singl variant analysi genet predict increas hdl c level associ decreas risk rvo glgc ci p consist ukb result ci p mvmr analysi plasma lipid adjust ci p diabet adjust ci p suggest low hdl c may independ risk factor rvo howev evid support causal associ ldl c glgc adjust ci p ukb ci p total cholesterol glgc adjust ci p ukb ci p triglycerid glgc ci p ukb ci p rvo use two sampl mr analysi studi suggest dyslipidemia risk factor rvo furthermor result indic low hdl c level may independ risk factor rvo suggest control hdl c level may effect rvo develop
|
D008076;D012164
|
T123;T047;T109
|
36,299,451
|
ece prognost biomark associ modif involv immun infiltr lung adenocarcinoma target therapi lung cancer reli prognost gene requir research research conduct determin effect endothelin convert enzym ece lung cancer
|
D000077192;D008175
|
T191
|
36,299,440
|
supervis semisupervis manifold embed knowledg transfer motor imageri base bci long calibr procedur limit use practic motor imageri mi base brain comput interfac bci system tackl problem consid supervis semisupervis transfer learn howev challeng cope high intersessionsubject variabl mi electroencephalograph eeg signal base framework unsupervis manifold embed knowledg transfer mekt propos supervis mekt algorithm smekt semisupervis mekt algorithm ssmekt respect smekt limit label sampl target subject abund label sampl multipl sourc subject compar smekt ssmekt add compar unlabel sampl target subject perform riemannian align ra tangent space map tsm smekt ssmekt execut domain adapt shorten differ among subject domain adapt make use avail sampl two algorithm preserv sourc domain discrimin ssmekt preserv geometr structur embed label unlabel target domain moreov obtain subject specif classifi smekt minim joint probabl distribut shift label target sourc domain wherea ssmekt perform joint probabl distribut shift minim unlabel target domain label domain experiment result two public avail mi dataset demonstr algorithm outperform six compet algorithm size label unlabel target domain variabl especi target subject label sampl unlabel sampl ssmekt show increas averag accuraci two abovement dataset compar previous best semisupervis transfer learn algorithm ra regular common spatial pattern weight adapt regular ra rcsp war respect therefor algorithm effect reduc need label sampl target subject import mi base bci applic
|
D062207
|
T074
|
36,299,439
|
acceler deep neural network train use field programm gate array convolut neural network cnn train often necessit consider amount comput resourc recent year sever studi propos cnn infer train acceler fpgas previous demonstr good perform energi effici speed process cnn requir addit comput resourc memori bandwidth fpga platform resourc usag time power consumpt larg dataset train constrain requir improv hardwar acceler support scalabl beyond exist data model size paper propos procedur energi effici cnn train collabor fpga base acceler employ optim quantize common model compress techniqu speed cnn train process addit gradient accumul buffer use ensur maximum oper effici maintain gradient descent learn algorithm valid design implement alexnet vgg model fpga board laptop cpu along side gpu achiev gop teras de soc alexnet model gop vgg model teras de soc result also exhibit fpga acceler energi effici platform
|
D016571;D000465
|
T170
|
36,299,438
|
influenc factor negat motiv colleg student english learn reli artifici neural network algorithm colleg english receiv increas focus import part educ system howev continu develop english instruct simultan promot student posit learn motiv english cours generat growth negat motiv becom common problem among colleg student student enthusiasm learn english cours gradual fade teacher teach valu also becom difficult guarante serious affect normal order progress educ teach activ therefor import healthi develop english teach understand studi affect element negat motiv english learn univers student provid scientif effect suggest teacher learner establish good teach learn attitud reli interpret negat motiv theori paper studi various influenc factor mean artifici neural network algorithm princip compon analysi method introduc improv tradit bp algorithm term frequenc iter length comput time realiz accur effici analysi colleg student english learn data result analysi reveal comprehens error algorithm analysi influenc factor rang calcul eigenvalu cumul contribut rate negat motiv influenc factor found factor curriculum set teach method teacher student relationship greatest influenc student negat motiv english learn eigenvalu respect cumul contribut rate reach respect aspect necessari improv aspect order elimin negat motiv learn
|
D009042;D013334
|
T078;T098;T080;T081;T041
|
36,299,437
|
applic imag super resolut reconstruct gymnast train use internet thing technolog imag super resolut reconstruct short restor clear imag imag conveni identifi general use intellig surveil system medic imag system hospit kind technolog appli mani tradit algorithm today ultra high resolut algorithm revis paper analyz detail converg characterist two wide use pixel pixel loss function theoret experiment perspect fulli consid converg characterist studi combin mae network mse advantag learn method use singl loss function train network train method improv network perform level chines gymnast relat high even said repres advanc level world mani gymnast train sharp turn focus train well train chines gymnast face similar problem help chines gymnast improv train qualiti becom major issu gymnast train stage
|
D006173;D000080487
|
T056;T170
|
36,299,414
|
identif analysi senesc relat gene head neck squamous cell carcinoma comprehens bioinformat approach head neck cancer sixth frequent cancer world major subtyp head neck squamous cell carcinoma hnscc cellular senesc associ gene confirm play critic role cancer potenti prognost biomark cancer clinic inform hnscc sampl express data acquir public databas express profil gene relat cellular senesc use identifi molecular subtyp consensus cluster screen differenti express gene deg differ subtyp differenti analysi perform use univari cox regress identifi prognost deg perform least absolut shrinkag select oper lasso optim construct prognost model cibersort estim tide tool appli estim immun characterist four molecular subtyp establish base cellular senesc associ gene differenti prognosi observ among differ subtyp c longest overal surviv c worst prognosi c subtyp also show highest immun infiltr screen total eight cellular senesc prognosi relat gene establish cellular senesc relat signatur score csrsscore could stratifi sampl high csrsscore low csrsscore group high csrsscore group wors prognosi lower immun infiltr lower respons immunotherapi improv prognost model surviv predict combin csrsscore clinicopatholog featur use decis tree model high predict accuraci surviv predict studi demonstr import role cellular senesc hnscc identifi eight cellular senesc associ gene potenti provid idea adjuv treatment person treatment hnscc patient
|
D019295;D006258
|
T191;T091
|
36,299,411
|
feasibl use high resolut comput tomographi featur invas differenti malign nodul manifest ground glass nodul ground glass nodul ggn like adenocarcinoma special subtyp lung cancer invas nodul correl well patient prognosi studi aim establish radiom model invas differenti malign nodul manifest ground glass high resolut comput tomographi hrct januari juli pulmonari nodul manifest ggns preoper hrcts whose histolog result avail collect nodul random classifi train n independ test n cohort three logist model use featur deriv hrct fit train cohort valid aforement cohort invas adenocarcinoma preinvas minim invas adenocarcinoma mia differenti model best perform present nomogram valid use calibr curv perform decis curv analysi benefit use propos model also shown group manag strategi recommend fleischner societi combin model show best differenti perform area curv auc train set test set quantit textur model show better perform auc train set test set semant model auc train set test set type nodul iac identifi model model use featur deriv imag effect differenti preinvas mia iac among lung adenocarcinoma appear ggns ct imag
|
D008175;D000230
|
T191
|
36,299,409
|
investig associ adolesc internet addict parent attitud object studi associ parent attitud internet addict among adolesc high school student investig sociodemograph variabl method research carri student studi four high school western turkey sociodemograph characterist parent attitud scale internet addict scale use studi descript statist logist regress analysi structur equat model analysi appli result result multivari logist regress analysi demonstr signific relationship combin mean score obtain parent attitud scale mean score obtain internet addict scale authoritarian parent attitud increas risk internet addict ci structur equat model analysi model summari fit valu determin good level df gfi rmsea regard relationship parent attitud internet addict conclus adolesc internet addict level chang relat parent democrat attitud evolv
|
D000082424;D016739
|
T048
|
36,299,408
|
preval parent peer support independ associ mental distress unhealthi behaviour countri object parent peer support associ mental distress unhealthi behaviour indic adolesc method use global school base student health survey data n countri calcul weight preval individu combin parent peer support multipl logist regress analysi use estim adjust associ combin parent peer support mental distress unhealthi behaviour result preval figur four categori parent support two peer support respect compar parent support adolesc four parent support negat associ five mental distress eight unhealthi behaviour factor or rang addit adolesc two peer support negat associ mental distress four health risk behaviour posit associ sedentari lifestyl conclus parent peer support lack countri greater parent peer support negat associ mental distress unhealthi behaviour adolesc relationship independ
|
D057185;D010290
|
T033;T099;T102;T079
|
36,299,407
|
alcohol screen brief intervent primari health care kazakhstan result cluster randomis pilot studi object aim pilot trial assess feasibl asbi primari health care unit phcus kazakhstan method two arm cluster randomis trial five phcus base aim framework implement studi carri patient audit c score femal male receiv brief face face intervent deliv train physician plus inform leaflet intervent group ig simpl feedback includ leaflet control group cg result among patient elig alcohol screen accord inclus criteria patient screen ig cg n test audit c posit ig cg physician invit took part asbi train final particip studi ig phcus cg phcus major physician difficulti perform intervent conclus asbi feasibl implement phc set kazakhstan howev implement depend willing interest phcu physician
|
D003419;D008403
|
T061;T060;T058
|
36,299,250
|
dedic team optim qualiti safeti surgeri systemat review dedic oper team defin surgic team consist group peopl work togeth time optim attun technic andor communic aspect achiev technic andor communic train team set dedic surgic team may contribut optim healthcar qualiti patient safeti within periop period
|
D010348;D003142
|
T080;T170;T054;T097;T058
|
36,299,243
|
stay go behavior act negat affect relationship prospect intim relationship easi keep high rate divorc singlehood testifi current research aim examin behavior act like negat effect peopl willing continu intim relationship specif use qualit research method sampl greek speak particip studi identifi act negat impact peopl willing continu intim relationship studi employ quantit research method sampl greek speak particip classifi act six broader factor one negat impact rate care follow treat well children tri control women singl particip rate identifi factor negat men particip relationship marri signific main effect age sex relationship status children also found sever factor
|
D012747;D012725
|
T098;T032;T055;T033;T053
|
36,299,230
|
research updat role innat immun cell pathogenesi abdomin aortic aneurysm
|
D017544
|
T047
|
36,299,229
|
research advanc role endoplasm reticulum stress arrhythmia relat heart failur na ca l k kr
|
D059865;D006333
|
T049;T047;T046
|
36,299,228
|
research advanc associ innat lymphoid cell cardiovascular diseas
|
D007113;D002318
|
T047;T032
|
36,299,227
|
two case endocardi pacemak implant subclavian vein infant complet atrioventricular block
|
D054537;D010138
|
T047;T074
|
36,299,226
|
case report laminopathi cardiomyopathi lmnalmna rw
|
D009202;D000083083
|
T047
|
36,299,225
|
case neonat hypertens caus renal arteri fibromuscular dysplasia
|
D005352;D006978;D012078;D006973
|
T047
|
36,299,224
|
status home blood pressur monitor influenc factor regular home blood pressur monitor among elder uncontrol hypertens patient central western china object describ preval home blood pressur monitor analyz factor influenc regular blood pressur monitor among elder uncontrol hypertens patient central western china method cross section studi enrol hypertens patient age year offic blood pressur mmhg mmhg kpa septemb juli hospit central western china patient complet electron questionnair divid regular irregular home blood pressur monitor group proport patient use differ type sphygmomanomet percentag patient regular home blood pressur monitor least week explor general linear mix model use defin influenc factor regular home blood pressur monitor result total patient includ studi age year old male overal sphygmomanomet avail home patient patient conduct regular home blood pressur monitor among patient sphygmomanomet home sphygmomanomet upper arm electron devic older age higher incom longer histori hypertens multipl antihypertens medic awar diagnost criteria hypertens hypertens complic associ higher preval regular home blood pressur monitor p conclus among elder hypertens patient uncontrol blood pressur central western china relat high preval home sphygmomanomet ownership regular monitor age famili incom histori hypertens number antihypertens drug knowledg hypertens influenc factor regular home blood pressur monitor popul
|
D018660;D006973
|
T060;T047
|
36,299,223
|
associ analysi genet variant matrix metalloproteinas enzym gene blood pressur children adolesc object explor associ genet variant matrix metalloproteinas enzym mmp gene blood pressur children adolesc method cross section studi perform includ children adolesc urban area guangzhou physic examin includ bodi height weight blood pressur questionnair includ general characterist physic exercis parent educ level household incom etc blood sampl perform multivari linear regress model use investig associ mmp genet variat rs rs genet risk score grs level standard blood pressur mediat effect standard bodi mass index bmi assess process analysi associ grs level blood pressur potenti addit interact physic activ grs level analyz use product term regress model result total primari secondari schoolchildren final includ analysi consist second grade pupil primari school first grade pupil middl school first grade student senior high school adjust age sex parent educ level famili incom compar rs tt genotyp ccct genotyp increas diastol blood pressur dbp standard deviat sd domin model ci compar rs cc genotyp aaac genotyp show sd higher systol blood pressur sbp recess model ci sd increas dbp recess model ci increment grs level sbp dbp increas sd domin model ci sd ci respect mediat effect bmi account total effect grs sbp dbp respect control bmi direct effect grs dbp remain statist signific p insuffici moder vigor physic activ hd show signific interact grs sbp addit scale interact ci p conclus rs rs variant mmp gene associ elev blood pressur children adolesc obes may yield mediat role associ insuffici physic activ may posit addit interact mmp genet variant
|
D001794;D006973;D020778
|
T116;T201;T040;T126;T047
|
36,299,222
|
associ high sensit c reactiv protein new onset hypertens differ age group object investig associ high sensit c reactiv protein hscrp level new onset hypertens differ age group method prospect cohort studi involv non hypertens popul kailuan group communiti particip health examin follow conduct everi year time new onset hypertens use endpoint follow endtim follow patient without hypertens time death last follow decemb accord baselin hscrp level particip divid low risk group hscrp mgl stratifi age kaplan meier method use calcul cumul incid hypertens group multivari cox regress model use analyz associ hscrp level new onset hypertens result total particip includ studi includ male averag age year baselin hscrp mgl baselin hscrp mgl respect low medium high risk group follow year total patient develop hypertens cumul incid rate low medium high risk group respect cumul incid hypertens low medium high risk group year old respect except peopl age year signific differ cumul incid hypertens low medium high risk group p multivari cox regress analysi show risk new onset hypertens high risk group time higher low risk group hr ci risk new onset hypertens high risk group time hr ci time hr ci time hr ci time hr ci low risk group year old group respect conclus higher hscrp level risk factor new onset hypertens risk develop hypertens caus elev hscrp age depend
|
D002097;D006973
|
T129;T047;T116
|
36,299,221
|
associ weight gain first half pregnanc risk hypertens disord pregnanc prospect cohort studi object explor associ weight gain first half pregnanc risk hypertens disord pregnanc hdp method prospect cohort studi recruit singleton pregnant women first trimest novemb march communiti hospit tianjin accord pre pregnanc bodi mass index bmi cohort divid group underweight bmi entir cohort compar rgwg kgweek rgwg kgweek prior week increas hdp risk rr ci p normal weight pregnant women rgwg kgweek face higher risk hdp rgwg kgweek rr ci p overweightobes group excess weight gain week seem increas risk hdp differ statist signific rr ci p connect nonexist underweight women conclus except pre pregnanc underweight women excess weight gain first half pregnanc associ increas risk hdp among pregnant women
|
D046110;D011248
|
T047;T046
|
36,299,220
|
chines expert consensus standard clinic applic cardiopulmonari exercis test cpetcpetcpet
|
D005080;D016887
|
T060;T061
|
36,299,219
|
chines expert consensus clinic applic percutan mechan circulatori support devic intervent therapi patient complex cardiovascular diseas percutan mechan circulatori supportpmcspmcspmcspmcspmcspmcspmc
|
D002318;D015199
|
T061;T047
|
36,299,218
|
rethink goal blood pressur hypertens patient mmhg mmhg kpasprint mmhg
|
D006040;D006973
|
T047;T170
|
36,299,217
|
neglect cardiovascular continuum hypertens disord pregnanc cardiovascular diseas hdphdpcvdcvd hdpcvdhdpcvd
|
D002318;D046110;D002319;D011225
|
T022;T047;T046
|
36,299,215
|
research advanc burn blister fluid burn often caus damag tissu produc larg amount exud format blister wound burn blister fluid contain larg number molecul relat wound heal reflect state local tissu microenviron burn wound analyz relev inform cellular compon signal mediat protein molecul burn blister fluid help understand local reaction tissu microenviron burn wound help clinic burn treatment articl understand product mechan burn blister fluid discuss role wound evalu integr research progress burn blister fluid proteom metabolom cellular compon pharmacokinet propos thought prospect research burn blister fluid order provid assist clinic evalu treatment burn wound also provid idea follow studi burn blister fluid
|
D001768;D002056
|
T033;T037
|
36,299,214
|
research advanc effect rna n methyladenosin modif relev pathophysiolog process wound repair n methyladenosin exist wide eukaryot post transcript modif modif dynam revers regul methyltransferas demethylas involv regul biolog effect bind protein recent studi elucid involv embryon skin morphogenesi wound repair pathophysiolog process inflammatori respons angiogenesi fibrosi review summar role relat protein relat pathophysiolog process wound repair provid new theoret basi treatment strategi wound repair
|
D012313;D000241
|
T123;T121;T114;T109
|
36,299,213
|
research advanc construct ideal scar model vitro base innov tissu engin technolog scar bring huge econom burden creat serious psycholog shadow patient although current method scar treatment tend diversifi treatment method truli achiev goal perfect heal scarless heal human skin injuri quit scarc wide applic tissu engin technolog medicin research technolog three dimension bioprint organoid cultur organ chip technolog constant emerg diseas model vitro base innov technolog show advantag tradit anim diseas model articl introduc current hotspot technolog skin tissu engin organoid cultur three dimension bioprint organ chip technolog focus summar three key element master construct ideal scar model vitro put forward futur prospect construct ideal scar model vitro base research team long term experi skin tissu repair regener research
|
D023822;D062028
|
T061;T063
|
36,299,212
|
research advanc applic natur recombin collagen wound repair collagen macromolecular protein constitut extracellular matrix anim connect tissu wide use develop field biomedicin tissu engin food cosmet due advantag abund sourc good biocompat low immunogen degrad collagen use dress tissu engin scaffold wound repair accord sourc materi collagen divid natur collagen recombin collagen natur collagen main extract direct mammal fish recombin collagen obtain base genet engin technolog sourc includ recombin express system microorgan anim plant paper summar sourc collagen role advantag disadvantag differ sourc collagen wound repair particular superior collagen combin three dimension print technolog wound repair impact market norm china collagen industri field wound repair explain precaut develop collagen relat product aim provid new idea select suitabl sourc collagen wound repair
|
D003094;D003358
|
T123;T121;T116;T073;T122;T167
|
36,299,211
|
research advanc applic silk fibroin biomateri wound repair silk fibroin natur fibrin suitabl matrix biomateri wound repair due uniqu properti good biocompat tunabl biodegrad mechan properti low host inflammatori respons low cost eas fabric etc silk fibroin use alon combin materi construct various dress includ scaffold hydrogel film smart mat microneedl meet need differ wound repair regul wound repair process thus applic research silk fibroin skin tissu engin increas dramat compar natur materi silk fibroin promot tissu regener wound repair improv cell prolifer migrat differenti behavior differ stage show uniqu advantag differ dimens base develop silk fibroin wound repair materi recent year review focus mechan applic prospect silk fibroin composit materi wound repair
|
D005349
|
T123;T116
|
36,299,210
|
research advanc construct artifici dermal scaffold base biomateri field wound repair scarless heal complet reconstruct skin function major challeng clinic basic research present varieti artifici dermal scaffold use clinic repair wound overcom problem skin structur disord caus tissu defect biomateri use make artifici dermal scaffold skin tissu engin research main includ three categori natur biomateri biosynthet materi organ polym materi review summar biocompat bioactiv degrad biomateri effect wound heal provid overview artifici dermal scaffold construct strategi base biomateri wound heal cell associ cytokin
|
D001672;D017768
|
T122
|
36,299,209
|
transplant bilater superfici inferior epigastr arteri perfor flap breast reconstruct patient unilater breast cancer may year old femal patient unilater breast cancer admit hunan cancer hospit underw modifi radic mastectomi right breast cancer free transplant bilater superfici inferior epigastr arteri perfor flap weigh g breast reconstruct oper right inferior epigastr vascular pedicl anastomos proxim end right intern mammari vessel left inferior epigastr vascular pedicl anastomos distal end right intern mammari vessel blood flow flap good wound donor site abdomin flap close direct oper last hour first hour post oper flap show mild elev perfus drainag obvious edema blister observ flap temperatur consist surround skin drainag volum drainag tube ml blood suppli flap complet restor normal day post oper flap surviv well donor site incis obvious tension heal smooth month follow donor site incis abdomen heal complet linear scar left reconstruct breast natur appear patient plan perform nippl reconstruct contralater breast mastopexi case suggest autolog breast reconstruct perform use bilater superfici inferior epigastr arteri perfor flap certain circumst minim donor site injuri greatest extent
|
D061525;D001943;D000069584;D016462
|
T061;T023;T191
|
36,299,208
|
clinic effect proxim ulnar arteri perfor flap combin iliac bone graft reconstruct subtot thumb finger defect object explor clinic effect proxim ulnar arteri perfor flap combin iliac bone graft reconstruct subtot thumb finger defect method retrospect observ studi conduct august august patient thumb finger defect caus mechan damag met inclus criteria admit ruihua affili hospit soochow univers includ male femal age year length finger repair iliac bone length cm bone graft skin defect area affect finger rang cm cm cm cm free proxim ulnar arteri perfor flap area cm cm cm cm use cover wound wound donor site iliac crest flap direct sutur surviv flap one week post surgeri donor site wound heal week post surgeri observ respect follow appear sensori function affect finger bone heal scar hypertrophi wound donor site observ evalu last follow function recoveri affect finger evalu trial standard evalu function upper limb hand surgeri societi chines medic associ result one week post surgeri flap surviv week post surgeri iliac bone wound forearm donor site heal follow month flap good appear without obvious pigment sensori recoveri reach level patient patient graft iliac bone boni union without obvious resorpt wound donor site heal well mild scar format last follow shape reconstruct finger close healthi finger function evalu result excel case good case conclus use proxim ulnar arteri perfor flap combin iliac bone graft reconstruct subtot thumb finger partial restor part appear function less damag donor site good choic patient low expect appear function reconstruct finger
|
D017695;D061525;D019651
|
T061;T023;T037
|
36,299,207
|
clinic applic effect sequenti nurs manag new skin face neck deep burn object explor clinic applic effect sequenti nurs manag new skin face neck deep burn method retrospect case control research approach use januari decemb patient met inclus criteria admit first affili hospit armi medic univers third militari medic univers within week deep burn wound heal face neck fifti five patient admit hospit januari june receiv comprehens treatment convent nurs includ convent nurs group male femal age year fifti four patient admit hospit juli decemb receiv comprehens treatment sequenti nurs includ sequenti nurs group male femal age year score pigment vascular pliabil thick vancouv scar scale vss total score vss score itch impact sleep four item itch questionnair fiiq total score fiiq patient count two group first treatment hereinaft refer treatment month month year treatment treatment effect rate score patient satisfact treatment effect one year treatment occurr advers reaction treatment count data statist analyz independ sampl test mann whitney u test chi squar test result score pigment vascular pliabil thick vss total vss score patient two group treatment close p pliabil score vss total vss score month treatment score vascular vss total vss score month treatment score pigment vascular pliabil thick vss total vss score patient year treatment sequenti nurs group signific lower convent nurs group z valu respect p p score itch impact sleep fiiq month treatment patient sequenti nurs group signific lower convent nurs group z p total score fiiq month month year treatment patient sequenti nurs group signific lower convent nurs group z valu respect p year treatment treatment effect rate patient sequenti nurs group signific higher convent nurs group p score patient satisfact treatment effect sequenti nurs group signific higher convent nurs group z p treatment period advers reaction patient sequenti nurs group patient pruritus peripher erythema wound convent nurs group improv dress chang conclus sequenti nurs effect improv prevent manag new skin scar patient deep burn face neck improv itch effici treatment satisfact patient treatment effect
|
D002056
|
T037
|
36,299,206
|
screen function analysi clinic valid differenti express gene diabet foot ulcer object screen differenti express gene deg diabet foot ulcer dfus perform function analysi clinic valid intend lay theoret foundat epigenet therapi chronic refractori wound method observ studi conduct gene express profil dataset gse dfu patient gene express omnibus geo select deg three normal skin tissu sampl six dfu tissu sampl dataset analyz screen use geor tool screen deg clusterprofil orghsegdb goplot ggplot r languag packag use gene ontolog go enrich analysi biolog process molecular function cellular compon kyoto encyclopedia gene genom kegg enrich analysi respect protein protein interact ppi analysi perform use string databas screen key gene deg go enrich analysi key gene perform use cytohubba plug cytoscap softwar dfu tissu normal skin tissu discard surgeri collect respect dfu patient male femal age year acut wound patient male femal age year admit xiangan hospit xiamen univers septemb march mrna protein express small prolin rich repeat protein sprra late cornifi envelop protein c lcec detect real time fluoresc quantit revers transcript polymeras chain reaction immunohistochemistri respect data statist analyz independ sampl test result compar normal skin tissu statist differenti express deg screen dfu tissu dfu patient correct p correct p includ regul deg regul deg go terminolog analysi show deg signific enrich aspect skin develop keratinocyt kc differenti keratin epiderm develop epiderm cell differenti etc correct p valu kegg pathway analysi show deg signific enrich aspect tumor associ microrna ras relat protein signal pathway pluripot stem cell regulatori signal pathway etc correct p valu ppi analysi show endophi protein sprra sprrb sprrb sprre sprrf lcec lcee keratin regul deg filoprotein regul deg key gene deg screen dfu tissu dfu patient signific enrich go term keratin kc differenti epiderm cell differenti skin develop epidermi develop peptid cross link etc correct p valu mrna express sprra lcec dfu tissu dfu patient respect protein express respect signific lower valu respect p valu valu respect p valu normal skin tissu acut wound patient conclus compar normal skin tissu deg profil dfu tissu dfu patient deg signific enrich aspect kc differenti keratin function key deg relat biolog function kc low express dfu tissu dfu patient may imped ulcer heal
|
D017719;D035683;D014945
|
T123;T047;T040;T114
|
36,299,205
|
compar studi effect second toe tibial dorsal arteri flap second toe tibial plantar proper arteri flap repair finger skin soft tissu defect object compar effect second toe tibial dorsal arteri flap tdaf second toe tibial plantar proper arteri flap tppaf repair finger skin soft tissu defect method retrospect cohort studi conduct januari june patient skin soft tissu defect fingertip area cm cm cm cm debrid met inclus criteria admit suzhou ruihua orthopaed hospit includ male femal age year accord flap repair method use defect finger patient divid tdaf group case tppaf group case area tdaf rang cm cm cm cm area tppaf rang cm cm cm cm full thick skin graft medial side ipsilater leg graft wound donor site wound donor site skin graft direct sutur flap arteri diamet flap excis time flap surviv situat patient week oper follow time record last follow two point discrimin distanc flap graft site total action motion tam finger joint wound heal flap donor site record vancouv scar scale vss use score scar donor area second toe recipi area finger appear self satisfact subscal michigan hand outcom questionnair mhq use evalu affect finger data statist analyz independ sampl test fisher exact probabl test result flap arteri diamet patient tdaf group mm flap cut time min signific shorter mm min tppaf group valu respect p conclus compar tppaf tdaf shallow anatom layer shorter time surgic flap remov preserv proper arteri nerv base toe reduc damag donor site
|
D017695;D005383;D019651;D061525
|
T061;T023;T037
|
36,299,204
|
clinic effect later supramalleolar perfor island flap low rotat point repair foot skin soft tissu defect wound object investig clinic effect later supramalleolar perfor island flap low rotat point repair foot skin soft tissu defect wound method retrospect observ studi conduct octob august patient male femal age year foot skin soft tissu defect wound admit lanzhou univers second hospit includ case plantar skin tumor case chronic plantar ulcer case foot traffic injuri case residu wound deep foot burn wound size cm cm cm cm tumor resect debrid repair island flap pedicl descend branch later supramalleolar perfor rotat point locat lower front edg later ankl size flap rang cm cm cm cm length vascular pedicl rang cm flap transfer subcutan tunnel repair wound donor site wound flap repair medium thick skin graft later thigh surviv flap wound heal donor recipi site occurr complic oper observ appear flap donor site foot function observ follow result flap patient surviv success oper wound donor recipi site heal well without vascular crisi venous congest complic follow month show flap good appear without bloat wear resist function wear shoe walk affect obvious scar hyperplasia hyperpigment donor site conclus descend branch later supramalleolar perfor pedicl rotat point locat lower front edg later ankl island flap good effect repair skin soft tissu defect wound foot reliabl blood suppli simpl design oper need vascular anastomosi low rotat point long vascular pedicl larg radius rotat
|
D061525;D019651;D017695;D018409
|
T061;T023;T037
|
36,299,203
|
effect mechan water solubl chitosan hydrogel infect full thick skin defect wound diabet mice object explor effect mechan water solubl chitosan hydrogel infect full thick skin defect wound diabet mice method experiment research method adopt control hydrogel compos polyvinyl alcohol gelatin water solubl chitosan hydrogel compos aforement two materi water solubl chitosan prepar cyclic freez thaw method fluiditi two dress test tube first freez thaw general observ differ appear final state two dress well plate compar accord random number tabl group method cell strain l hacat divid water solubl chitosan hydrogel group control hydrogel group respect ad correspond dress cultur h cell prolifer activ measur use cell count kit rabbit blood erythrocyt suspens divid normal salin group polyethylen glycol octyl phenyl ether triton x group water solubl chitosan hydrogel group control hydrogel group treat accord incub hour hemolysi degre erythrocyt detect micropl reader twenti four femal dbdb mice age week select full thick skin defect wound back inflict inocul methicillin resist staphylococcus aureus mrsa h later mice divid blank control group sulfadiazin silver hydrogel group control hydrogel group water solubl chitosan hydrogel group treat accord post injuri day pid immedi heal wound observ pid wound heal rate calcul pid mrsa concentr wound determin pid wound histolog analyz hematoxylin eosin stain express cd wound detect immunofluoresc method posit percentag calcul raw cell taken divid interleukin il group blank control group control hydrogel group water solubl chitosan hydrogel group treat accord h cultur percentag cd posit cell detect flow cytometri number sampl data statist analyz independ sampl test one way analysi varianc analysi varianc repeat measur least signific differ test dunnett test result two dress test tube certain fluiditi freez thaw form semi solid gel freez thaw final form two dress well plate basic stabl transluc sheet littl differ transpar h cultur cell prolifer activ l hacat water solubl chitosan hydrogel group signific higher control hydrogel group valu respect p h incub hemolysi degre erythrocyt water solubl chitosan hydrogel group signific lower triton x group p pid traumat condit mice group similar pid yellowish exud observ insid wound blank control group control hydrogel group small amount exud observ wound sulfadiazin silver hydrogel group water solubl chitosan hydrogel group pid wound blank control group control hydrogel group dri crust without obvious epitheli coverag sulfadiazin silver hydrogel group scab fell purul exud visibl wound water solubl chitosan hydrogel group base wound light red obvious epitheli coverag could observ wound pid wound heal rate water solubl chitosan hydrogel group signific higher group p pid wound water solubl chitosan hydrogel group complet close wound group complet heal wound heal rate water solubl chitosan hydrogel group signific higher group p pid concentr mrsa wound water solubl chitosan hydrogel group signific lower blank control group p pid new epidermi sever damag blank control group epidermi wound control hydrogel group also larg area defect complet new epidermi yet form wound sulfadiazin silver hydrogel group wound water solubl chitosan hydrogel group complet cover new epidermi basal cell new epidermi also regular align pid percentag cd posit wound water solubl chitosan hydrogel group signific higher blank control group control hydrogel group sulfadiazin silver hydrogel group p signific higher blank control group control hydrogel group p p conclus water solubl chitosan hydrogel good biosafeti induc higher level macrophag polar control hydrogel without water solubl chitosan enhanc repair effect mrsa infect full thick skin defect wound diabet mice promot rapid wound heal
|
D048271;D003921;D055624
|
T121;T007;T050;T109
|
36,299,202
|
effect p microspher load thermosensit chitosan hydrogel wound heal full thick skin defect rat object explor effect p microspher load thermosensit chitosan hydrogel wound heal full thick skin defect rat method method experiment studi adopt polyvinyl alcoholsodium algin microspher simpl microspher p microspher bovin serum albumin label fluorescein isothiocyan fitc bsa microspher prepar water oil emulsif morpholog observ light microscopeinvert fluoresc microscop chitosan solut prepar chitosan solut glycerol phosphat disodium hydrat mix prepar simpl thermosensit hydrogel thermosensit hydrogel load simpl microspher p microspher prepar ad correspond substanc simpl thermosensit hydrogel morpholog chang prepar four liquid state tilt observ freez dri micromorpholog prepar four liquid observ scan electron microscop eighteen week old male spragu dawley rat divid normal group without treatment dress group chitosan group hydrogel alon group simpl microspher load hydrogel group p microspher load hydrogel group inflict one full thick skin defect wound side back spine dealt correspond rat group rat full thick skin defect five group collect wound heal observ post injuri day pid immedi wound heal rate pid calcul wound wound margin tissu rat full thick skin defect five group pid normal skin tissu site rat normal group collect hematoxylin eosin stain conduct observ histolog chang immunohistochem stain perform observ express cd vascular endotheli growth factor vegf western blot conduct detect protein express cd vegf number sampl three data statist analyz one way analysi varianc analysi varianc repeat measur bonferroni correct result simpl microspher spheric loos porous surfac surfac p microspher fitc bsa microspher smooth without pore fitc bsa microspher emit uniform green fluoresc diamet three microspher basic consist compar chitosan solut simpl thermosensit hydrogel structur two microspher load hydrogel stabl state tilt two microspher load hydrogel denser network structur chitosan solut simpl thermosensit hydrogel cross section microspher diamet could seen within pid wound rat five group heal differ degre wound heal rat p microspher load hydrogel group best pid wound heal rate rat dress group chitosan group respect signific lower p microspher load hydrogel group p p wound heal rate rat hydrogel alon group pid simpl microspher load hydrogel group pid respect signific lower p microspher load hydrogel group p epidermi hair follicl sebac gland could seen normal skin rat normal group without posit express cd vegf wound rat p microspher load hydrogel group pid almost complet epitheli blood vessel hair follicl sebac gland posit express cd vegf wound rat full thick skin defect four group protein express cd vegf rat five group conclus p microspher load thermosensit chitosan hydrogel releas encapsul drug slowli prolong drug action time promot wound heal rat full thick skin defect promot wound angiogenesi epitheli
|
D048271;D012868;D017695
|
T121;T019;T037;T109
|
36,299,201
|
situ monitor regul local reactiv oxygen speci level promot wound repair local oxid stress inflammatori respons essenti procedur wound repair determin progress prognosi qualiti wound repair reactiv oxygen speci one import index reflect oxid stress inflammatori respons bodi consid promis target regul wound inflamm recent rapid develop nanomedicin research group research group success develop various diagnosi treatment reagent reactiv oxygen speci interdisciplinari integr monitor regul reactiv oxygen speci wound real time final achiev goal improv speed qualiti wound repair thus provid new strategi direct diagnosi treatment local inflammatori respons wound articl summar reactiv oxygen speci regulatori target local inflammatori respons wound situ monitor precis regul reactiv oxygen speci
|
D014945;D018384
|
T049;T040
|
36,299,200
|
research progress relationship dietari pattern metabol associ fatti liver diseas global metabol asssoci fatti liver diseas becom signific health burden due complex pathogenesi specif effect therapeut drug date onset progress metabol asssoci fatti liver diseas close associ improp dietari habit cornerston treat metabol asssoci fatti liver diseas weight loss well balanc diet articl summar discuss research progress home abroad relationship metabol asssoci fatti liver diseas dietari pattern mediterranean diet dash diet energi restrict balanc diet low fat diet low carbohydr diet western diet anim food diet tradit diet other addit categor effect various dietari pattern prevent treatment induct sever issu need metabol asssoci fatti liver diseas research subsequ refer
|
D065626;D038441
|
T061;T047
|
36,299,199
|
research progress compound inject tradit chines medicin treatment liver cancer incid mortal liver cancer high serious threaten human life health common treatment method liver cancer includ surgic treatment transcathet arteri chemoembol target therapi radiotherapi chemotherapi etc method various problem use alon paper review research treatment liver cancer compound inject tradit chines medicin mechan recent year order provid refer clinic treatment improv prognosi liver cancer
|
D008113;D016461;D006528;D004365
|
T061;T123;T191;T121
|
36,299,198
|
hepat c elimin among drug user china challeng strategi experi preval hepat c among drug user china high thus one popul need attent achiev hepat c elimin howev due complex popul situat hepat c elimin still face mani challeng difficult screen low cure rate poor complianc high reinfect rate therefor exist diagnost therapeut system meet need popul china pledg establish unifi system drug user integr drug treatment program educ medic care rehabilit creat favor condit integr hepat c diagnosi treatment improv access drug user start current situat challeng elimin hepat c among drug user china combin case countri paper discuss strategi elimin hepat c introduc hainan provinc elimin hepat c among drug user
|
D055030;D006526
|
T033;T047;T098;T101
|
36,299,197
|
mechan clinic signific hbv reactiv anti hcv therapi direct act antivir daa strong inhibit replic hepat c virus hcv effect clear infect may caus hepat b virus hbv reactiv lead sever liver damag fulmin hepat patient hcvhbv coinfect review summar differ replic process hcv hbv infect hepatocyt consequ innat immun respons discuss molecular mechan clinic signific hbv reactiv put forward clinic precaut
|
D019698;D006526;D060085;D006509
|
T047
|
36,299,196
|
case eighteen year post splenectomi follow thrombophlia gastrointestin bleed initi present symptom due portal hypertens
|
D006975;D004932
|
T047;T020
|
36,299,195
|
case multifoc extramedullari hematopoiesi misdiagnos primari liver cancer concomit multipl system metastas emhemh
|
D006411;D008113
|
T191;T042
|
36,299,194
|
random control clinic trial quick screen model symptomat bacterascit guid antibiot therapi object investig clinic signific quick screen model symptomat bacterascit guid antibiot therapi method data collect prospect case cirrhot ascit newli admit nanchang ninth hospit septemb februari clear indic antibiot treatment use number polymorphonuclear cell ascit th day treatment number complet respons experiment group control group number partial respons number non respons z p respons rate signific better experiment group control group vs p conclus guid antibiot therapi somehow import quick screen model symptomat bacterascit patient cirrhot ascit test posit model benefit antibiot therapi
|
D001424;D008403
|
T060;T047;T058
|
36,299,193
|
chines qualiti life scale reliabl valid test non alcohol fatti liver diseas object translat english version non alcohol fatti liver diseas qualiti life scale cldq nafld chines version order test reliabl valid method english version cldq nafld translat accord cross cultur research tool debug valid guidelin form chines version cldq nafld questionnair survey conduct nafld case tertiari hospit hangzhou septemb april evalu reliabl valid scale result chines version cldq nafld contain six domain total thirti six item xdf rmsea tli cfi ifi cvi cviua cviav respect item short form health survey sf use calibr standard correl valid calibr standard p cronbach alpha coeffici total scale dimens scale respect test retest reliabl conclus chines version cldq nafld good reliabl valid thus use evalu qualiti life nafld patient chines cultur background
|
D011788;D065626
|
T078;T047
|
36,299,192
|
abc prognost classif meld cossh aclf prognost evalu acut chronic liver failur object investig abc prognost classif updat version model end stage liver diseas meld score chines group studi sever hepat b aclf score cossh aclf score evalu prognost valu acut chronic liver failur aclf method abc classif perform follow cohort area receiv oper characterist curv auroc use analyz meld meld cossh cossh score day hospit cossh prognost predict abil patient evalu day predict differ differ classif differ etiolog prognosi aclf compar result surviv curv case aclf show differ class b c statist signific log rank mantel cox p compar class c p auroc confid interv ci analyz meld meld cossh cossh respect p cossh better prognost predict abil class aclf hbv relat aclf hbv aclf day auroc ci respect p meld prognost predict valu better meld conclus aclf prognosi close relat abc classif cossh score high predict valu prognost evalu class aclf hbv aclf cossh score better prognost evalu valu day hospit suggest attent paid treatment aclf earli stage admiss
|
D065290;D058625
|
T047
|
36,299,191
|
clinic signific hepat b virus pgrna decid antivir therapi discontinu patient chronic hepat b object explor clinic signific hepat b pregenom rna pgrna decid antivir therapi discontinu patient chronic hepat b chb method data patient chb treat long term antivir therapi center infecti diseas west china hospit sichuan univers januari decemb collect drug discontinu evalu high sensit hbv dna hbv pgrna hbv dna iuml hbv pgrna copiesml
|
D006515;D019694
|
T005;T047
|
36,299,190
|
cluster classif clinic prognost model base rna methyl regul liver cancer object cluster classif base methyl regul construct prognost evalu model method util consensus cluster classifi liver cancer sampl form tcga base express methyl regul verifi function prognost signific cluster subtyp marker gene screen construct risk predict model evalu prognosi liver cancer patient result two cluster subtyp base methyl regul show signific differ prognosi valu liver cancer patient p prognost marker relat methyl liver cancer screen subgroup poor prognosi two regulatori gene ythdf ythdf prove advers prognosi univari cox analysi p use lasso regress method build risk assess model effect predict prognosi status liver cancer patient within year year auc year auc moreov assess model valid anoth dataset asia liver cancer patient conclus studi provid idea studi methyl liver cancer risk predict model use evalu short term prognosi liver cancer patient
|
D000241;D008113
|
T123;T121;T109;T191;T114
|
36,299,189
|
gnbl gene express clinic valu hepatocellular carcinoma base bioinformat object analyz guanin nucleotid bind protein subunit beta like gnbl express base bioinformat evalu role relationship surviv rate occurr develop hepatocellular carcinoma method gepia ualcan hpa databas use analyz express level gnbl relationship hcc surviv rate mutat gnbl gene impact surviv analyz use cbioport databas linkedom databas use analyz gnbl relat gene hcc gene ontolog go function annot kyoto encyclopedia gene genom pathway enrich analysi perform simultan ste databas use construct gnbl protein interact network timer databas use analyz relationship gnbl gene express immun infiltr hepatocellular carcinoma differenti express gnbl plasma platelet hcc patient healthi control analyz use mrna base sequenc technolog data group compar use independ sampl test result gnbl express level signific increas hcc tissu p express signific correl bodi weight classif stage p overal surviv rate higher gnbl low express group p gnbl relat gene relat biolog process regul metabol process protein bind oxid phosphoryl jak stat signal pathway ras signal pathway gnbl interact rps rps rpl particip multipl biolog process liver regener posit regul endogen apoptot signal pathway gnbl express signific posit correl infiltr degre various immun cell hcc p cox regress analysi show gnbl independ risk factor lower surviv rate patient hcc hazard ratio confid interv p gnblexpress level signific higher platelet hcc patient healthi control vs p conclus gnbl high express close relationship surviv rate hcc therefor gnbl may potenti biomark hcc
|
D006528;D008113
|
T191
|
36,299,188
|
alter wnta overexpress earli monitor valu hepatocellular carcinogenesi object investig dynam express pattern carcinoembryon wnta earli monitor valu use hepatocellular carcinoma model method forti eight spragu dawley sd rat fed pellet feed contain acetylaminofluoren aaf induc hepatocarcinogenesi control rat fed pellet diet liver tissu blood sampl collect everi two week liver tissu patholog examin use stain group gene wnta mrna express analyz genom wide microarray express distribut wnta liver tissu analyz immunohistochemistri wnta concentr liver tissu serum quantifi enzym link immunosorb assay statist method test mann whitney test analysi varianc use analyz differ group result accord patholog examin result rat liver divid four group control hepatocyt degener precancer lesion hepatocellular carcinoma genom wide express profil analysi comparison control group reveal gene regul gene regul precancer cancer group signal logarithm ratio slr log cyci signific alter gene main involv cell prolifer signal transduct tumor metastasi apoptosi express wnta mrna level signific increas stage cancer induct includ degener group q precancer group q cancer group q compar control group f p degener group precancer group liver cancer group regul fold respect immunohistochemistri show compar control group posit rate wnta degener group p precancer liver cancer group posit p wnta express gradual increas liver blood sampl process carcinogenesi differ two group statist signific f p wnta overexpress secret blood stream via cancer liver tissu linear correl wnta level blood liver sampl r p conclus wnta overexpress close relat hepatocellular carcinogenesi thus may becom new monitor marker
|
D006528;D008113;D011230
|
T191
|
36,299,187
|
retrospect control studi tace haic target immun quadrupl therapi intermedi advanc stage hepatocellular carcinoma object evalu efficaci safeti transcathet arteri chemoembol tace hepat arteri infus chemotherapi haic target immun quadrupl therapi patient intermedi advanc stage hepatocellular carcinoma hcc method patient intermedi advanc stage hcc enrol accord inclus exclus criteria divid combin group control group patient combin group treat tace haic target immun quadrupl therapi control group treat tace therapi overal surviv os progress free surviv pfs treatment relat advers reaction statist analyz two group patient statist analysi carri test test rank sum test kaplan meier curv log rank test cox regress proport hazard model analysi accord differ data result tumor object respons rate diseas control rate evalu mrecist criteria combin group respect signific higher control group p p os pfs combin group month ci na month ci respect signific better control group month ci p month ci p gastric ulcer incid signific higher combin group control group p conclus tace haic target immun quadrupl therapi effect treatment mode intermedi advanc stage hcc tace alon attent paid monitor target immun relat advers reaction
|
D006528;D016461;D008113
|
T061;T191
|
36,299,186
|
recommend easl clinic practic guidelin haemochromatosi haemochromatosi characteris elev transferrin satur tsat progress iron load main affect liver earli diagnosi treatment phlebotomi prevent cirrhosi hepatocellular carcinoma diabet arthropathi complic patient homozyg pcystyr hfe provision iron overload base serum iron paramet tsat ferritin gl femal tsat ferritin gl male postmenopaus women suffici diagnos haemochromatosi patient high tsat elev ferritin hfe genotyp diagnosi requir presenc hepat iron overload mri liver biopsi stage liver fibrosi end organ damag care assess diagnosi determin diseas manag patient advanc fibrosi includ screen programm hepatocellular carcinoma treatment target phlebotomi ferritin gl induct phase gl mainten phase
|
D006432;D006528;D019190;D008113
|
T047;T191
|
36,299,185
|
introduct recommend european associ studi liver clinic practic guidelin manag cystic liver diseas diagnosi cystic liver diseas made great progress advent enhanc imag techniqu time manag gradual improv past decad provid basi develop appropri diagnost treatment guidelin end european associ studi liver develop clinic guidelin diagnosi treatment non infecti cystic liver diseas guidelin put forward recommend base depth review relev literatur address clinic issu includ diagnosi treament hepat cyst hepat mucocyst tumor biliari hamartoma polycyst liver diseas caroli diseas caroli syndrom biliari hamartoma peribiliari cyst
|
D008107;D003560;D016767;D008113;D006222
|
T190;T191;T033;T019;T047
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.